MDT

84.83

+1.33%↑

VEEV

231.93

+3.06%↑

A

107.72

+1.87%↑

WBA

10.97

+0.09%↑

CHE

581.87

+4%↑

MDT

84.83

+1.33%↑

VEEV

231.93

+3.06%↑

A

107.72

+1.87%↑

WBA

10.97

+0.09%↑

CHE

581.87

+4%↑

MDT

84.83

+1.33%↑

VEEV

231.93

+3.06%↑

A

107.72

+1.87%↑

WBA

10.97

+0.09%↑

CHE

581.87

+4%↑

MDT

84.83

+1.33%↑

VEEV

231.93

+3.06%↑

A

107.72

+1.87%↑

WBA

10.97

+0.09%↑

CHE

581.87

+4%↑

MDT

84.83

+1.33%↑

VEEV

231.93

+3.06%↑

A

107.72

+1.87%↑

WBA

10.97

+0.09%↑

CHE

581.87

+4%↑

Search

Essa Pharma Inc

Open

1.75

Overview

Share price change

24h

Current

Min

1.68

Max

1.78

Key metrics

By Trading Economics

Income

-2.2M

-8.5M

EPS

-0.272

Employees

35

EBITDA

-3.6M

-9.9M

Market Stats

By TradingEconomics

Market Cap

79M

Previous open

1.75

Previous close

1.75

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Essa Pharma Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 kwi 2025, 23:27 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- 2nd Update

28 kwi 2025, 23:07 UTC

Top News

Woodside Energy Approves $17.5 Billion Louisiana LNG Development -- Update

28 kwi 2025, 23:03 UTC

Earnings

Waste Management 1Q Profit Falls, Revenue Misses Estimates

28 kwi 2025, 23:47 UTC

Market Talk

Gold Edges Lower as Traders Assess Mixed Signals From Treasury Secretary Bessent -- Market Talk

28 kwi 2025, 23:17 UTC

Earnings

Jiangxi Copper 1Q Rev CNY111.61B Vs. CNY122.52B >0358.HK

28 kwi 2025, 23:17 UTC

Earnings

Jiangxi Copper 1Q Net CNY1.95B Vs. Net CNY1.71B >0358.HK

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities: Higher Interest Income, Fee Income Also Aided 1Q Results>600999.SH

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities 1Q Rev CNY4.71B Vs. CNY4.30B >600999.SH

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities: Gains From Investments in Financial Instruments Supported Results >600999.SH

28 kwi 2025, 23:13 UTC

Earnings

China Merchants Securities 1Q Net CNY2.31B Vs. Net CNY2.16B >600999.SH

28 kwi 2025, 23:08 UTC

Earnings

China Longyuan Power: 1Q Power Generation Declined 4.42% on Year>0916.HK

28 kwi 2025, 23:08 UTC

Earnings

China Longyuan Power 1H Rev CNY8.14B Vs. CNY8.07B >0916.HK

28 kwi 2025, 23:08 UTC

Earnings

China Longyuan Power 1H Net CNY1.98B Vs. Net CNY2.53B >0916.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power: 1Q Net Was Mainly Driven By Decline in Domestic Fuel Costs >0902.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power: Decrease in Electricity Tariffs Weighed on Rev >0902.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power 1Q Rev CNY60.33B ; Down 7.7% on Year>0902.HK

28 kwi 2025, 23:04 UTC

Earnings

Huaneng Power 1Q Net CNY4.97B; up 8.2% on Year >0902.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway 1Q Rev CNY4.78B Vs. CNY3.47B >0177.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway: 1Q Rev Rose Due to Increase in Road Construction Projects >0177.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway: Decline in Investment Income, Fall in Revenue Post Asset Disposal Weighed on 1Q Net >0177.HK

28 kwi 2025, 23:00 UTC

Earnings

Jiangsu Expressway 1Q Net CNY1.21B Vs. Net CNY1.25B >0177.HK

28 kwi 2025, 22:57 UTC

Top News

Trump Signs Order Requiring Nationwide List of Sanctuary Cities and States -- 8th Update

28 kwi 2025, 22:55 UTC

Earnings

Tsingtao Brewery: Higher Sales Volumes of Beer Supported Results >0168.HK

28 kwi 2025, 22:55 UTC

Earnings

Tsingtao Brewery 1Q Net CNY1.71B Vs. Net CNY1.60B >0168.HK

28 kwi 2025, 22:55 UTC

Earnings

Tsingtao Brewery 1Q Rev CNY10.45B Vs. CNY10.15B >0168.HK

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding: Results Supported by Higher Contributions From Logistics Business >002352.SZ

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding 1Q Net CNY2.23B Vs. Net CNY1.91B >002352.SZ

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding: Cost Controls Also aided 1Q Results >002352.SZ

28 kwi 2025, 22:52 UTC

Earnings

S.F. Holding 1Q Rev CNY69.85B Vs. CNY65.34B >002352.SZ

28 kwi 2025, 22:46 UTC

Earnings

Shandong Gold Mining: Increase in Selling Price of Gold Supported Results>600547.SH

Peer Comparison

Price change

Essa Pharma Inc Forecast

Rating Consensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

1.75 / 1.79Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Essa Pharma Inc

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.